Tweets
Some new #vaccination #recommendations
#EULAR2026
@RheumNow https://t.co/j7cOJPpOcV https://t.co/VnGkFwTZ86
Links:
Janet Pope @Janetbirdope ( View Tweet )
5 hours 4 minutes ago
Remember
Babies of pts on chronic #immunosuppression with #SARDs
❎delay #vaccinations til 6/12
For safety & to mount sufficient response
#rotovirus #vaccine is Ok before 6 months or vaccine is ineffective
Pts w #SARDs need #COVID shots
@RheumNow #EULAR2026 #vaccine #recom https://t.co/WEzNajWlxY
Links:
Janet Pope @Janetbirdope ( View Tweet )
5 hours 4 minutes ago
What’s new with the 2026 update of reco for vax in AIIRD?
Vaccinate as soon as possible
Non-live vaccines are safe
Hold MTX for upto 2wks to inc vax yield
Strong reco for RZV
Catch-up vax for HPV in SLE
Rotavirus vax for newborns exposed in utero to TNFi
@RheumNow #EULAR2026 https://t.co/RZbyvAcYRI
Links:
sheila @RHEUMarampa ( View Tweet )
5 hours 4 minutes ago
#EULAR2026 #SARD #vaccination #recommendations
I think 🤔
✅proactive➡️take responsibility
✅close gap
✅mostly practical
But
How long will #shingrix work if #vaccine
In age<50yrs
When if ever
To revaccinate?
@RheumNow @eular_org @ACRheum https://t.co/najJwzdecL
Links:
Janet Pope @Janetbirdope ( View Tweet )
5 hours 4 minutes ago
#OP0156 #EULAR2026 FT839, CART therapy targeting CD19 & CD38, showed potent depletion of pathogenic B cells, plasmablasts/plasma cells & activated T cells, w/o conditioning chemotherapy. Data suggest potentially more accessible CART approach across autoimmune diseases. @RheumNow https://t.co/9COyXbghkl
Mrinalini Dey @DrMiniDey ( View Tweet )
5 hours 4 minutes ago
Updated SLR on D2T #RA (131 studies): JAKi maintain ACR20 even after 2-3 prior bDMARDs, with UPA outperforming ABA in head-to-head. But evidence on non-pharmacologic strategies in D2T RA remains nearly absent. Clear gap for future trials. @RheumNow #EULAR2026 POS1246
Jiha Lee @JihaRheum ( View Tweet )
5 hours 4 minutes ago
Good performance of #definite
#antisynthetase #syndrome
✅+antibody mandatory
Possible also does ok
@RheumNow #EULAR2026
June 6 #antisynthetase #classifiaction #criteria https://t.co/5sxogTX9YT
Links:
Janet Pope @Janetbirdope ( View Tweet )
5 hours 4 minutes ago
Steroid use remain common in rheumatology, despite risks even low-dose, especially for older adults.
"Steroids and Me" (Sam) provides online patient education ~5 minutes.
@RheumNow #EULAR2026 POS1388
Jiha Lee @JihaRheum ( View Tweet )
5 hours 4 minutes ago
Dr. Cavagna presents the 2025 EULAR/ACR Classification Criteria for Anti-Synthetase Syndrome
He emphasizes the inportance of ruling out anti-MDA5 Ab & anti-PM/Scl Ab DM since these conditions share overlapping features w/ ASyS.
@RheumNow #EULAR2026 https://t.co/AtGRlp5qyW
Links:
sheila @RHEUMarampa ( View Tweet )
5 hours 4 minutes ago
#OP0159 #EULAR2026
Multimodal study in D2T RA identified altered brain connectivity patterns linked to pain, psychological features & peripheral transcriptomics. Supports neuroimmune component in D2T RA & need for personalised approaches beyond inflammation control. @RheumNow https://t.co/qMQbkiMCwX
Mrinalini Dey @DrMiniDey ( View Tweet )
5 hours 4 minutes ago
Does #RA accelerate age-related functional decline in older adults? STAR study (n=421, age 55-85): RA with worse HAQ, grip strength, but aging's effect on function similar in RA vs controls. Geriatric syndromes like sarcopenia may matter more than RA @RheumNow #EULAR2026 POS0360
Jiha Lee @JihaRheum ( View Tweet )
5 hours 4 minutes ago
Thoracic U/S for #RA-ILD screening? Multicenter study (n=272, Argentina/Denmark/Belgium): 86% sensitivity and 94% NPV. Accessible, no radiation, integrates into clinic flow. Time to build TUS into routine RA-ILD pathways? @RheumNow #EULAR2026 POS1265 https://t.co/FGH5iUstxa
Jiha Lee @JihaRheum ( View Tweet )
5 hours 4 minutes ago
